EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 123 filers reported holding EXELIXIS INC in Q2 2015. The put-call ratio across all filers is 3.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $467,736 | +124.5% | 20,816 | +137.1% | 0.01% | +100.0% |
| Q1 2024 | $208,349 | +3.4% | 8,780 | +4.5% | 0.00% | 0.0% |
| Q4 2023 | $201,516 | -93.6% | 8,400 | -96.6% | 0.00% | -97.3% |
| Q3 2016 | $3,158,000 | -79.0% | 246,907 | -93.8% | 0.15% | -70.7% |
| Q2 2015 | $15,040,000 | +46.3% | 4,000,000 | 0.0% | 0.50% | +50.5% |
| Q1 2015 | $10,280,000 | +613.9% | 4,000,000 | +300.0% | 0.33% | +540.4% |
| Q4 2014 | $1,440,000 | -5.9% | 1,000,000 | 0.0% | 0.05% | -7.1% |
| Q3 2014 | $1,530,000 | -54.9% | 1,000,000 | 0.0% | 0.06% | -58.8% |
| Q2 2014 | $3,390,000 | +6.4% | 1,000,000 | +11.1% | 0.14% | +4.6% |
| Q1 2014 | $3,186,000 | – | 900,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
| GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
| Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
| CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
| EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
| CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
| Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
| Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |